Subcateneous apomorphine in Parkinson's disease: response to chronic administration for up to five years
Identifieur interne : 003677 ( PascalFrancis/Checkpoint ); précédent : 003676; suivant : 003678Subcateneous apomorphine in Parkinson's disease: response to chronic administration for up to five years
Auteurs : A. J. Hughes [Royaume-Uni] ; S. Bishop ; B. Kleedorfer ; N. Turjanski ; W. Fernandez ; Andrew Lees (neurologue) [Royaume-Uni] ; G. M. SternSource :
- Movement disorders [ 0885-3185 ] ; 1993.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
Pascal:93-0457158Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Subcateneous apomorphine in Parkinson's disease: response to chronic administration for up to five years</title>
<author><name sortKey="Hughes, A J" sort="Hughes, A J" uniqKey="Hughes A" first="A. J." last="Hughes">A. J. Hughes</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Middlesex hosp., dep. neurology</s1>
<s2>London WC1N 8AA</s2>
<s3>GBR</s3>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>London WC1N 8AA</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bishop, S" sort="Bishop, S" uniqKey="Bishop S" first="S." last="Bishop">S. Bishop</name>
</author>
<author><name sortKey="Kleedorfer, B" sort="Kleedorfer, B" uniqKey="Kleedorfer B" first="B." last="Kleedorfer">B. Kleedorfer</name>
</author>
<author><name sortKey="Turjanski, N" sort="Turjanski, N" uniqKey="Turjanski N" first="N." last="Turjanski">N. Turjanski</name>
</author>
<author><name sortKey="Fernandez, W" sort="Fernandez, W" uniqKey="Fernandez W" first="W." last="Fernandez">W. Fernandez</name>
</author>
<author><name sortKey="Lees, A J" sort="Lees, A J" uniqKey="Lees A" first="A. J." last="Lees">Andrew Lees (neurologue)</name>
<affiliation><country>Royaume-Uni</country>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
<orgName>National Hospital for Neurology and Neurosurgery</orgName>
</affiliation>
</author>
<author><name sortKey="Stern, G M" sort="Stern, G M" uniqKey="Stern G" first="G. M." last="Stern">G. M. Stern</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">93-0457158</idno>
<date when="1993">1993</date>
<idno type="stanalyst">PASCAL 93-0457158 INIST</idno>
<idno type="RBID">Pascal:93-0457158</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">003750</idno>
<idno type="wicri:Area/PascalFrancis/Curation">003074</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">003677</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Subcateneous apomorphine in Parkinson's disease: response to chronic administration for up to five years</title>
<author><name sortKey="Hughes, A J" sort="Hughes, A J" uniqKey="Hughes A" first="A. J." last="Hughes">A. J. Hughes</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Middlesex hosp., dep. neurology</s1>
<s2>London WC1N 8AA</s2>
<s3>GBR</s3>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>London WC1N 8AA</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bishop, S" sort="Bishop, S" uniqKey="Bishop S" first="S." last="Bishop">S. Bishop</name>
</author>
<author><name sortKey="Kleedorfer, B" sort="Kleedorfer, B" uniqKey="Kleedorfer B" first="B." last="Kleedorfer">B. Kleedorfer</name>
</author>
<author><name sortKey="Turjanski, N" sort="Turjanski, N" uniqKey="Turjanski N" first="N." last="Turjanski">N. Turjanski</name>
</author>
<author><name sortKey="Fernandez, W" sort="Fernandez, W" uniqKey="Fernandez W" first="W." last="Fernandez">W. Fernandez</name>
</author>
<author><name sortKey="Lees, A J" sort="Lees, A J" uniqKey="Lees A" first="A. J." last="Lees">Andrew Lees (neurologue)</name>
<affiliation><country>Royaume-Uni</country>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
<orgName>National Hospital for Neurology and Neurosurgery</orgName>
</affiliation>
</author>
<author><name sortKey="Stern, G M" sort="Stern, G M" uniqKey="Stern G" first="G. M." last="Stern">G. M. Stern</name>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1993">1993</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson agent</term>
<term>Chemotherapy</term>
<term>Chronic</term>
<term>Human</term>
<term>Parkinson disease</term>
<term>Subcutaneous administration</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Chronique</term>
<term>Traitement</term>
<term>Homme</term>
<term>Chimiothérapie</term>
<term>Apomorphine</term>
<term>Antiparkinsonien</term>
<term>Voie souscutanée</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>8</s2>
</fA05>
<fA06><s2>2</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Subcateneous apomorphine in Parkinson's disease: response to chronic administration for up to five years</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>HUGHES (A. J.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>BISHOP (S.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>KLEEDORFER (B.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>TURJANSKI (N.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>FERNANDEZ (W.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>LEES (A. J.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>STERN (G. M.)</s1>
</fA11>
<fA14 i1="01"><s1>Middlesex hosp., dep. neurology</s1>
<s2>London WC1N 8AA</s2>
<s3>GBR</s3>
</fA14>
<fA20><s1>165-170</s1>
</fA20>
<fA21><s1>1993</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000036117700070</s5>
</fA43>
<fA44><s0>0000</s0>
</fA44>
<fA45><s0>22 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>93-0457158</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B02B06</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Parkinson maladie</s0>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Chronique</s0>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Chronic</s0>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Crónico</s0>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Traitement</s0>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Treatment</s0>
</fC03>
<fC03 i1="03" i2="X" l="GER"><s0>Aufbereiten</s0>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Tratamiento</s0>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Homme</s0>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Human</s0>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Hombre</s0>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Chimiothérapie</s0>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Chemotherapy</s0>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Quimioterapia</s0>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Apomorphine</s0>
<s2>NK</s2>
<s2>FR</s2>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Antiparkinsonien</s0>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Antiparkinson agent</s0>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Antiparkinsoniano</s0>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Voie souscutanée</s0>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Subcutaneous administration</s0>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Vía subcutánea</s0>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
</fC07>
<fN21><s1>187</s1>
</fN21>
</pA>
</standard>
</inist>
<affiliations><list><country><li>Royaume-Uni</li>
</country>
<region><li>Angleterre</li>
<li>Grand Londres</li>
</region>
<settlement><li>Londres</li>
</settlement>
<orgName><li>National Hospital for Neurology and Neurosurgery</li>
</orgName>
</list>
<tree><noCountry><name sortKey="Bishop, S" sort="Bishop, S" uniqKey="Bishop S" first="S." last="Bishop">S. Bishop</name>
<name sortKey="Fernandez, W" sort="Fernandez, W" uniqKey="Fernandez W" first="W." last="Fernandez">W. Fernandez</name>
<name sortKey="Kleedorfer, B" sort="Kleedorfer, B" uniqKey="Kleedorfer B" first="B." last="Kleedorfer">B. Kleedorfer</name>
<name sortKey="Stern, G M" sort="Stern, G M" uniqKey="Stern G" first="G. M." last="Stern">G. M. Stern</name>
<name sortKey="Turjanski, N" sort="Turjanski, N" uniqKey="Turjanski N" first="N." last="Turjanski">N. Turjanski</name>
</noCountry>
<country name="Royaume-Uni"><noRegion><name sortKey="Hughes, A J" sort="Hughes, A J" uniqKey="Hughes A" first="A. J." last="Hughes">A. J. Hughes</name>
</noRegion>
<name sortKey="Lees, A J" sort="Lees, A J" uniqKey="Lees A" first="A. J." last="Lees">Andrew Lees (neurologue)</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003677 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 003677 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PascalFrancis |étape= Checkpoint |type= RBID |clé= Pascal:93-0457158 |texte= Subcateneous apomorphine in Parkinson's disease: response to chronic administration for up to five years }}
This area was generated with Dilib version V0.6.23. |